Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-005236
Filing Date
2014-11-07
Accepted
2014-11-07 07:30:38
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-10q_20140930.htm 10-Q 1440051
2 EX-31.1 ardx-ex311_201409307.htm EX-31.1 12715
3 EX-31.2 ardx-ex312_201409306.htm EX-31.2 12754
4 EX-32.1 ardx-ex321_201409308.htm EX-32.1 6865
  Complete submission text file 0001564590-14-005236.txt   5215515

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ardx-20140930.xml EX-101.INS 665816
6 XBRL TAXONOMY EXTENSION SCHEMA ardx-20140930.xsd EX-101.SCH 33286
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ardx-20140930_cal.xml EX-101.CAL 34942
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ardx-20140930_def.xml EX-101.DEF 101526
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ardx-20140930_lab.xml EX-101.LAB 285686
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ardx-20140930_pre.xml EX-101.PRE 209924
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 141202668
SIC: 2834 Pharmaceutical Preparations